Please Wait
| Date | 3/31/2023 | 12/31/2022 | 3/31/2022 | 2/28/2013 | 8/31/2012 | 5/31/2012 | 2/29/2012 | 8/31/2011 | 5/31/2011 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $572.00 | $751.00 | -- | $115.00 | $54.00 | $533.00 | $1,212.00 | $7,528.00 | $31,940.00 |
| Accounts Receivable Net Current | $90,797.00 | $374,003.00 | -- | -- | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Prepaid Expenses and Other Current Assets | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Current Assets | $92,888.00 | $376,273.00 | -- | $209.00 | $54.00 | $533.00 | -- | -- | -- |
| Property Plant and Equipement | -- | -- | -- | $13,128.00 | $13,483.00 | $13,660.00 | -- | -- | -- |
| Intangible Assets Net | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Assets | $2,738,969.00 | $2,791,472.00 | -- | -- | -- | -- | -- | -- | -- |
| Total Assets | $3,743,743.00 | $4,079,631.00 | -- | $13,337.00 | $13,537.00 | $14,193.00 | -- | -- | -- |
| Accounts Payable | $947,015.00 | $1,191,025.00 | -- | $23.00 | $23.00 | $23.00 | -- | -- | -- |
| Accrued Liabilities | $456,560.00 | $426,842.00 | -- | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $3,452,131.00 | $3,781,262.00 | -- | -- | -- | -- | -- | -- | -- |
| Long Term Debt | $23,511.00 | $23,167.00 | -- | -- | -- | -- | -- | -- | -- |
| Additional Paid-in Capital | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Other Comprehensive Loss | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Accumulated Deficit | $-2,327,106.00 | $-2,320,349.00 | -- | -- | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $291,612.00 | $298,369.00 | -- | $-32,727.00 | $-16,037.00 | $-21,554.00 | -- | -- | -- |
| Controlling Interest in Subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Liabilities and Equity | $3,743,743.00 | $4,079,631.00 | -- | $13,337.00 | $13,537.00 | $14,193.00 | -- | -- | -- |
| Date | 3/31/2023 | 12/31/2022 | 3/31/2022 | 2/28/2013 | 8/31/2012 | 5/31/2012 | 2/29/2012 | 8/31/2011 | 5/31/2011 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | $242,320.00 | -- | $649,857.00 | -- | -- | -- | $5,465.00 | -- | -- |
| Cost of Revenues | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | $2,311.00 | $2,311.00 | -- | $2,499.00 | -- | -- |
| Research and Development | $119,645.00 | -- | $256,856.00 | -- | -- | -- | -- | -- | -- |
| Selling, General, and Administrative | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Total Operating Expenses | $210,551.00 | -- | $424,975.00 | $105,077.00 | $39,233.00 | -- | $7,126.00 | $20,830.00 | -- |
| Loss from Operations | $31,769.00 | -- | $224,882.00 | -- | -- | -- | -- | -- | -- |
| Loss Before Income Taxes | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Earnings Per Share Basic | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Basic | 514,226,791 | -- | 514,226,791 | -- | -- | -- | -- | -- | -- |
| Earnings Per Share Diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Weighted Average Shares Diluted | 514,226,791 | -- | 514,226,791 | -- | -- | -- | -- | -- | -- |
| Common Stock Shares Authorized | 950,000,000 | 950,000,000 | -- | -- | -- | -- | -- | -- | -- |
| Common Stock Shares Outstanding | 514,226,791 | 514,226,791 | -- | -- | -- | -- | -- | -- | -- |
| Common Stock Value | $514,227.00 | $514,227.00 | -- | $66,000.00 | $66,000.00 | $20,000.00 | -- | -- | -- |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | -- | -- | -- | -- | -- | -- | -- |
| Payments Of Dividends Common Stock | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Authorized | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Shares Outstanding | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Preferred Stock Value | -- | -- | -- | $1,275.00 | $1,275.00 | $1,275.00 | -- | -- | -- |
| Preferred Stock Par Or Stated Value Per Share | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Share Price | -- | -- | -- | -- | -- | -- | -- | -- | -- |